ATG
Showing 1 - 25 of 702
Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)
Not yet recruiting
- Advanced Solid Tumors
- B-cell Non-Hodgkin Lymphomas
- (no location specified)
Aug 31, 2023
Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)
Not yet recruiting
- Severe Aplastic Anemia
- Busulfan
- Flu/Cy/ATG or Cy/ATG
- (no location specified)
Oct 1, 2023
Diabetes, Type 1 Trial (Antithymocyte Globulin, Placebo (for ATG))
Recruiting
- Diabetes Mellitus, Type 1
- Antithymocyte Globulin
- Placebo (for ATG)
-
Gainesville, FloridaUniversity of Florida
Jan 5, 2023
Advanced/Metastatic Solid Tumors Trial in Australia, China (ATG-022)
Not yet recruiting
- Advanced/Metastatic Solid Tumors
-
Adelaide, Australia
- +3 more
Jan 30, 2023
Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)
Recruiting
- Solid Tumor
- Hematological Malignancy
-
East Melbourne, Victoria, Australia
- +4 more
Jan 11, 2023
Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)
Recruiting
- Haploidentical Hematopoietic Stem Cell Transplantation
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 11, 2023
Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in China (ATG-010 and ATG-008)
Recruiting
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- ATG-010 and ATG-008
-
Chongqing, Chongqing, China
- +5 more
Sep 2, 2022
Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))
Recruiting
- Severe Aplastic Anemia
- Anti-Thymocyte Globulin (Rabbit)
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Sep 9, 2023
The Optimization of Haploidentical Hematopoietic Stem Cell
Not yet recruiting
- Hematological Malignancy
- ATG
- Post-transplantation cyclophosphamide
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Nov 28, 2022
Multiple Myeloma Trial in Zhengzhou, Wuhan, Xi'an (Selinexor (80mg/d), Selinexor (100mg/d), Pegylated liposomal doxorubicin)
Recruiting
- Multiple Myeloma
- Selinexor (80mg/d)
- +4 more
-
Zhengzhou, Henan, China
- +4 more
Aug 16, 2022
ATG5 as a Serum Marker of Autophagy in Psoriatic Patient
Recruiting
- Psoriasis Vulgaris
- Autophagy
- serum ATG5
-
Sohag, EgyptSohag University
Mar 6, 2022
Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)
Recruiting
- Graft Vs Host Disease
- +5 more
- Cyclophosphamide
- ATG
-
Augsburg, Germany
- +15 more
Aug 2, 2022
Advanced Solid Tumors, Hematological Malignancies Trial (ATG-018)
Not yet recruiting
- Advanced Solid Tumors
- Hematological Malignancies
- (no location specified)
Apr 14, 2022
Solid Tumor, Non-Hodgkin's Lymphoma Trial in China, Taiwan (ATG-019, ATG-019 + Niacin ER)
Recruiting
- Solid Tumor, Non-Hodgkin's Lymphoma
- ATG-019
- ATG-019 + Niacin ER
-
Nanjing, Jiangsu, China
- +7 more
Aug 11, 2022
Severe Aplastic Anemia (SAA) Trial in Worldwide (eltrombopag, rabbit anti-thymocyte globulin (r-ATG), cyclosporine A (CsA))
Active, not recruiting
- Severe Aplastic Anemia (SAA)
- eltrombopag
- +2 more
-
Zhengzhou, Henan, China
- +11 more
Jan 23, 2023
aGVHD, cGVHD Trial in Beijing (Rabbit ATG)
Recruiting
- aGVHD
- cGVHD
- Rabbit ATG
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Feb 21, 2022
Hematopoietic Stem Cell Transplantation, Acute Leukemia Trial in Suzhou (Individual ATG, ATG)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Acute Leukemia
- Individual ATG
- ATG
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 12, 2022
Ridge Augmentation, Implant, Autogenous Tooth Graft Trial in Kafr Ash Shaykh (ABB and ATG with simultaneous implant placement,
Recruiting
- Ridge Augmentation
- +2 more
- ABB and ATG with simultaneous implant placement
- +2 more
-
Kafr Ash Shaykh, EgyptFaculty of Dentistry, Kafrelsheikh University
Aug 5, 2022
Aplastic Anemia Trial in Beijing (Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit)
Not yet recruiting
- Aplastic Anemia
- Ciclosporin
- +2 more
-
Beijing, ChinaPeking union medical college hospital
Aug 16, 2023
Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid
Active, not recruiting
- Mycoses
- +5 more
- anti-thymocyte globulin
- +2 more
-
Stanford, CaliforniaStanford University School of Medicine
Jun 16, 2022